IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 114 filers reported holding IGM BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,534,302 | -16.2% | 90,200 | +12.1% | 0.00% | 0.0% |
| Q3 2022 | $1,830,000 | +24.9% | 80,450 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $1,465,000 | +746.8% | 81,263 | +684.1% | 0.00% | – |
| Q1 2022 | $173,000 | -81.3% | 10,364 | -67.2% | 0.00% | -100.0% |
| Q4 2021 | $927,000 | -58.7% | 31,611 | -7.4% | 0.00% | -50.0% |
| Q3 2021 | $2,245,000 | -28.1% | 34,139 | -9.0% | 0.00% | -33.3% |
| Q2 2021 | $3,121,000 | +2.2% | 37,508 | -5.8% | 0.00% | 0.0% |
| Q1 2021 | $3,053,000 | +8.3% | 39,811 | +24.7% | 0.00% | 0.0% |
| Q4 2020 | $2,818,000 | +172.8% | 31,914 | +128.0% | 0.00% | +200.0% |
| Q3 2020 | $1,033,000 | +659.6% | 13,997 | +475.1% | 0.00% | – |
| Q1 2020 | $136,000 | -3.5% | 2,434 | -34.0% | 0.00% | – |
| Q4 2019 | $141,000 | – | 3,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |